Kathmandu: Zydin Biotech Ltd., reported as Nepal’s first producer of raw materials for cancer medicines, has received Good Manufacturing Practices (GMP) certification for its Active Pharmaceutical Ingredient (API) manufacturing block. According to the certificate supplied by the company, the Department of Drug Administration issued the certification on October 9, 2026, following an inspection conducted on August 25–26. The certificate remains valid until October 8, 2028, subject to continued compliance with GMP requirements. The certified facility is located in Sharanpur, Bharatpur–16, Chitwan. Its approved scope covers cytotoxic APIs, including synthesis, purification, packing, labelling, quality control and quality assurance. APIs are the…
स्वास्थ्य डायरी
Kathmandu — Arya Pharmalab has signed a three-year agreement with the Cricket Association of Nepal (CAN) to serve as the health partner of the Nepal Premier League (NPL). The partnership marks the company’s entry into its 30th year of operation. According to the company, the collaboration aims to raise public health awareness through cricket and promote the connection between sport and healthy living. Through the NPL, Arya plans to provide basic health check-ups, consultations and information on maintaining a healthy lifestyle. The partnership includes health screening facilities, consultations and awareness activities at the Tribhuvan University International Cricket Ground. The company…
Kathmandu, October 24 — Today is World Polio Day. Although Nepal has not recorded a polio case for many years, challenges remain. With the disease yet to be eradicated globally, continued vaccination and surveillance are essential to protecting the country’s progress. Nepal last recorded a case caused by naturally circulating, or wild, poliovirus in 2010. No new cases caused by this virus have been reported since. However, missed vaccinations, cross-border movement and ongoing transmission in other countries continue to pose risks. Nepal’s experience shows that reaching zero cases does not mean the risk has ended. According to the Ministry of…
CHITWAN, October 16: Bharatpur Hospital has prioritised managing growing patient numbers, improving the quality of care, introducing technology-supported services and expanding its physical infrastructure. The initiatives aim to make specialist healthcare more accessible, affordable and convenient for the public. Dr Bishwabandhu Bagale has been serving as the hospital’s 49th chief medical superintendent since Chaitra 26. This is his second term in the role. Hospital records show that he previously served as its 39th medical superintendent from Jestha 2 to Ashadh 18, 2076 BS. Dr Bagale said the hospital had introduced several digital arrangements to simplify access to services and reduce…
Kathmandu, October 15: The Department of Drug Administration (DDA) has made it clear that there is no ban on the sale, distribution or use of medicines that are already in the market. The department released a press statement following confusion over its decision on the production and import of 47 medicine brands. According to the DDA the new production and import of these medicines have been paused because the companies involved did not submit required risk assessment documents on time or meet the standards. Even though the relevant certificates may be canceled the medicines that are already imported or in…
Kathmandu, December 16 – Prof. Dr. Mohanraj Sharma officially assumed his duties as the newly appointed Dean of the Institute of Medicine (IOM) under Tribhuvan University on Monday, pledging to work in the best interest of the institution without any political bias or external pressure. During the handover ceremony, former Dean Prof. Dr. Divya Singh Shah, along with faculty members, staff, and students, welcomed Dr. Sharma with warm gestures. Speaking to Health Diary following the ceremony, Dr. Sharma stated that he already has a strategic work plan for operating the institute and will proceed accordingly. “I am not affiliated with…